HKAPI Archives - Page 8 of 11

17 Mar 23

HKAPI Representatives visited Nan Sha, Guangdong

Representatives from the HKAPI GBA task force recently participated in a two-day trip to Nan Sha, Guangdong, on March 16-17.

11 Mar 23

Ms Sabrina Chan shared her insights on PGx trend in a recent webinar

Ms Sabrina Chan, Senior Executive Director of HKAPI, was invited to be one of the speakers at a recent webinar about pharmacogenetics on 11 March.

01 Mar 23

Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry

Over 30 members attended the seminar on-site, and 50 joined virtually.

01 Mar 23

Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry

In this seminar, representatives from Linklaters will cover key enforcement trends in the past year, as well as provide you with insights into proceedings in the Competition Tribunal. We will also discuss how this is relevant to the pharmaceutical industry in Hong Kong and practical tips to ensure full compliance with competition law.

13 Feb 23

Briefing session for Regulatory Intelligence Survey

The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.

13 Feb 23

Briefing Session for Regulatory Intelligence Survey

The Regulatory Working Group will kick off an all-year-long survey on Regulatory Intelligence to learn from members the latest practices of local & overseas regulators that may bring systemic impact […]

11 Jan 23

Code of Practice Train-the-Trainer Workshop 2023

More than 260 members attended the Code of Practice Train-the-Trainer Workshop on 11 January 2023 to understand the key changes of the Code and its implications for HKAPI members.

09 Jan 23

Appointment of New Board Member

We are pleased to announce that Mr. Derek Chang has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 9th January 2023.

January 9, 2023
vickyhkapi
No Comments

The DH met virtually with pharmaceutical associations to discuss a series of measures to maintain the steady supply of medicines.

09 Nov 22

2nd CEO Meeting (2022-24)

Over 20 CEOs and directors from our member companies joined the 2nd CEO Meeting of the term (2022-24) held online on 9 November 2022.

HKAPI Representatives visited Nan Sha, Guangdong

Ms Sabrina Chan shared her insights on PGx trend in a recent webinar

Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry

Hong Kong Competition Law Update – Recent enforcement trends and impact on pharmaceutical industry

Briefing session for Regulatory Intelligence Survey

Briefing Session for Regulatory Intelligence Survey

Code of Practice Train-the-Trainer Workshop 2023

Appointment of New Board Member

DH met with HKAPI on maintaining steady supply of paracetamol

2nd CEO Meeting (2022-24)

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use